Buy Allakos Inc Stock | ALLK Stock Price & Latest News | Public.com
ALLK

Allakos Inc

$0.00 (0.00%)Today
    View Allakos Inc (ALLK) stock trends here

    About ALLK

    Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis,...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.32
    -0.64
    -0.96
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.96

    Actual EPS
    Q1 2021

    Stats

    Market Cap$6,21B
    Volume248,02k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$157.98
    1 Year Low$41.60
    Open$118.51
    High$124.99
    Low$115.82

    Buy any stock with any amount of money.

    Download the App
    Download the app